| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 77,762 | -42 |
| Net increase in cash and cash equivalents | 61,758 | -10,824 |
| Cash and cash equivalents at beginning of period | 36,746 | - |
| Cash and cash equivalents at end of period | 98,504 | - |
vTv Therapeutics Inc. (VTVT)
vTv Therapeutics Inc. (VTVT)